Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate

In the title cholesterol analogue, [systematic name: (3S,8S,9S,10R,13S,14S,17R)-17-{(S)-1-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl]-6-methylheptan-2-yl}-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol] C32H53N3O2, a new chain, including an in...

Full description

Bibliographic Details
Main Authors: Hugo Santalla, Saray Argibay
Format: Article
Language:English
Published: International Union of Crystallography 2018-04-01
Series:Acta Crystallographica Section E: Crystallographic Communications
Subjects:
Online Access:http://scripts.iucr.org/cgi-bin/paper?S2056989018003286
_version_ 1819294725843189760
author Hugo Santalla
Saray Argibay
author_facet Hugo Santalla
Saray Argibay
author_sort Hugo Santalla
collection DOAJ
description In the title cholesterol analogue, [systematic name: (3S,8S,9S,10R,13S,14S,17R)-17-{(S)-1-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl]-6-methylheptan-2-yl}-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol] C32H53N3O2, a new chain, including an intermediate triazole and a tertiary hydroxyl group in the terminal position, has been added at position 20 inducing a change in its stereochemistry. In the crystal, molecules are linked by O—H...O and O—H...N hydrogen bonds, forming layers lying parallel to (-201) and enclosing R44(36) ring motifs. The isopropyl group is disordered about two positions with a refined occupancy ratio of 0.763 (5):0.237 (5). A region of disordered electron density was corrected for using the SQUEEZE routine in PLATON (Spek (2015). Acta Cryst. C71, 9–18). The given chemical formula and other crystal data do not take into account the unknown solvent molecule(s).
first_indexed 2024-12-24T04:30:53Z
format Article
id doaj.art-8aeb1070de9b4fa797b9038576409d1f
institution Directory Open Access Journal
issn 2056-9890
language English
last_indexed 2024-12-24T04:30:53Z
publishDate 2018-04-01
publisher International Union of Crystallography
record_format Article
series Acta Crystallographica Section E: Crystallographic Communications
spelling doaj.art-8aeb1070de9b4fa797b9038576409d1f2022-12-21T17:15:25ZengInternational Union of CrystallographyActa Crystallographica Section E: Crystallographic Communications2056-98902018-04-0174446546810.1107/S2056989018003286ex2005Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvateHugo Santalla0Saray Argibay1Departamento de Química Orgánica, Instituto de Investigación Sanitaria Galicia Sur, Facultade de Química, Universidade de Vigo, E-36310, Vigo, SpainDepartamento de Química Inorgánica, Instituto de Investigación Sanitaria Galicia Sur, Facultade de Química, Universidade de Vigo, E-36310, Vigo, SpainIn the title cholesterol analogue, [systematic name: (3S,8S,9S,10R,13S,14S,17R)-17-{(S)-1-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl]-6-methylheptan-2-yl}-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol] C32H53N3O2, a new chain, including an intermediate triazole and a tertiary hydroxyl group in the terminal position, has been added at position 20 inducing a change in its stereochemistry. In the crystal, molecules are linked by O—H...O and O—H...N hydrogen bonds, forming layers lying parallel to (-201) and enclosing R44(36) ring motifs. The isopropyl group is disordered about two positions with a refined occupancy ratio of 0.763 (5):0.237 (5). A region of disordered electron density was corrected for using the SQUEEZE routine in PLATON (Spek (2015). Acta Cryst. C71, 9–18). The given chemical formula and other crystal data do not take into account the unknown solvent molecule(s).http://scripts.iucr.org/cgi-bin/paper?S2056989018003286crystal structurecholesterolgeminianaloguehydrogen bonding
spellingShingle Hugo Santalla
Saray Argibay
Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
Acta Crystallographica Section E: Crystallographic Communications
crystal structure
cholesterol
gemini
analogue
hydrogen bonding
title Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
title_full Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
title_fullStr Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
title_full_unstemmed Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
title_short Crystal structure of (20S)-21-[4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methylpentyl)-5-pregnen-3β-ol with an unknown solvate
title_sort crystal structure of 20s 21 4 2 hydroxypropan 2 yl 1h 1 2 3 triazol 4 yl 20 4 methylpentyl 5 pregnen 3β ol with an unknown solvate
topic crystal structure
cholesterol
gemini
analogue
hydrogen bonding
url http://scripts.iucr.org/cgi-bin/paper?S2056989018003286
work_keys_str_mv AT hugosantalla crystalstructureof20s2142hydroxypropan2yl1h123triazol4yl204methylpentyl5pregnen3bolwithanunknownsolvate
AT sarayargibay crystalstructureof20s2142hydroxypropan2yl1h123triazol4yl204methylpentyl5pregnen3bolwithanunknownsolvate